LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Return on equity 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-2898.0%FY2025 · since FY2016: -5.5% → -2898.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2898.0% | -3004.1 pp |
| FY2024 | 106.2% | — |
| FY2022 | -132.9% | -116.9 pp |
| FY2021 | -16.0% | +0.6 pp |
| FY2020 | -16.6% | -16.8 pp |
| FY2019 | 0.2% | -9.7 pp |
| FY2018 | 9.8% | +5.2 pp |
| FY2017 | 4.7% | +10.2 pp |
| FY2016 | -5.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LFCR financial trends
LFCR RevenueLFCR Net incomeLFCR Net marginLFCR Gross profitLFCR Gross marginLFCR Operating incomeLFCR Operating marginLFCR Operating cash flowLFCR Free cash flowLFCR Capital expendituresLFCR Stock buybacksLFCR Dividends paidLFCR Total assetsLFCR Total liabilitiesLFCR Shareholders’ equityLFCR overview →